246 related articles for article (PubMed ID: 8708020)
1. Long-term results of topical immunotherapy in children with alopecia totalis or alopecia universalis.
Tosti A; Guidetti MS; Bardazzi F; Misciali C
J Am Acad Dermatol; 1996 Aug; 35(2 Pt 1):199-201. PubMed ID: 8708020
[TBL] [Abstract][Full Text] [Related]
2. Hair Regrowth Outcomes of Contact Immunotherapy for Patients With Alopecia Areata: A Systematic Review and Meta-analysis.
Lee S; Kim BJ; Lee YB; Lee WS
JAMA Dermatol; 2018 Oct; 154(10):1145-1151. PubMed ID: 30073292
[TBL] [Abstract][Full Text] [Related]
3. Topical therapy of alopecia areata with squaric acid dibutylester.
Case PC; Mitchell AJ; Swanson NA; Vanderveen EE; Ellis CN; Headington JT
J Am Acad Dermatol; 1984 Mar; 10(3):447-50. PubMed ID: 6725657
[TBL] [Abstract][Full Text] [Related]
4. Topical squaric acid dibutylester therapy for alopecia areata: a double-sided patient-controlled study.
Chua SH; Goh CL; Ang CB
Ann Acad Med Singap; 1996 Nov; 25(6):842-7. PubMed ID: 9055014
[TBL] [Abstract][Full Text] [Related]
5. Topical immunotherapy in children with alopecia areata.
Orecchia G; Malagoli P
J Invest Dermatol; 1995 May; 104(5 Suppl):35S-36S. PubMed ID: 7738389
[No Abstract] [Full Text] [Related]
6. Seventeen cases of alopecia areata: combination of SADBE topical immunotherapy with other therapies.
Morita K; Nakamura M; Nagamachi M; Kishi T; Miyachi Y
J Dermatol; 2002 Oct; 29(10):661-4. PubMed ID: 12433000
[TBL] [Abstract][Full Text] [Related]
7. Treatment of severe alopecia areata with squaric acid dibutylester in pediatric patients.
Orecchia G; Malagoli P; Santagostino L
Pediatr Dermatol; 1994 Mar; 11(1):65-8. PubMed ID: 8170854
[TBL] [Abstract][Full Text] [Related]
8. Treatment of alopecia areata with squaric acid dibutylester.
Micali G; Cicero RL; Nasca MR; Sapuppo A
Int J Dermatol; 1996 Jan; 35(1):52-6. PubMed ID: 8838932
[TBL] [Abstract][Full Text] [Related]
9. Successful treatment of alopecia areata-like hair loss with the contact sensitizer squaric acid dibutylester (SADBE) in C3H/HeJ mice.
Freyschmidt-Paul P; Sundberg JP; Happle R; McElwee KJ; Metz S; Boggess D; Hoffmann R
J Invest Dermatol; 1999 Jul; 113(1):61-8. PubMed ID: 10417620
[TBL] [Abstract][Full Text] [Related]
10. Treatment of alopecia areata with squaric acid dibutylester.
Caserio RJ
Arch Dermatol; 1987 Aug; 123(8):1036-41. PubMed ID: 3307636
[TBL] [Abstract][Full Text] [Related]
11. Topical immunotherapy for alopecia areata: re-evaluation of 139 cases after an additional follow-up period of 19 months.
van der Steen PH; Boezeman JB; Happle R
Dermatology; 1992; 184(3):198-201. PubMed ID: 1392112
[TBL] [Abstract][Full Text] [Related]
12. Effect of topical immunotherapy with squaric acid dibutylester for alopecia areata in Japanese patients.
Sakai K; Fukushima S; Mizuhashi S; Jinnin M; Makino T; Inoue Y; Ihn H
Allergol Int; 2020 Apr; 69(2):274-278. PubMed ID: 31767273
[TBL] [Abstract][Full Text] [Related]
13. Topical immunotherapy of alopecia areata. A follow-up study.
Valsecchi R; Cainelli T; Foiadelli L; Rossi A
Acta Derm Venereol; 1986; 66(3):269-72. PubMed ID: 2426909
[TBL] [Abstract][Full Text] [Related]
14. Topical immunotherapy with squaric acid dibutylester: unusual hair pigmentary changes in two cases of alopecia areata.
Mastrolonardo M; Diaferio A
J Eur Acad Dermatol Venereol; 2002 Mar; 16(2):186. PubMed ID: 12046838
[No Abstract] [Full Text] [Related]
15. Topical squaric acid dibutylester therapy for alopecia areata.
Flowers FP; Slazinski L; Fenske NA; Pullara TJ
Cutis; 1982 Dec; 30(6):733-6. PubMed ID: 6756800
[No Abstract] [Full Text] [Related]
16. [Controlled study of the efficacy of topical immunotherapy in alopecia areata: squaric acid versus placebo].
Pigatto PD; Rapisarda R; Polenghi MM; Altomare GF
G Ital Dermatol Venereol; 1987 Dec; 122(12):667-70. PubMed ID: 3329149
[No Abstract] [Full Text] [Related]
17. Topical immunotherapy in the treatment of chronic severe alopecia areata.
Shapiro J
Dermatol Clin; 1993 Jul; 11(3):611-7. PubMed ID: 8365043
[TBL] [Abstract][Full Text] [Related]
18. Normalisation of hair follicle morphology in C3H/HeJ alopecia areata mice after treatment with squaric acid dibutylester.
Gardner S; Freyschmidt-Paul P; Hoffmann R; Sundberg JP; Happle R; Lindsey NJ; Tobin DJ
Eur J Dermatol; 2000 Aug; 10(6):443-50. PubMed ID: 10980465
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of topical sensitizers in the treatment of alopecia areata.
Rokhsar CK; Shupack JL; Vafai JJ; Washenik K
J Am Acad Dermatol; 1998 Nov; 39(5 Pt 1):751-61. PubMed ID: 9810892
[TBL] [Abstract][Full Text] [Related]
20. Squaric acid sensitization is not required for response in the treatment of alopecia areata.
Vedak P; Kroshinsky D
J Am Acad Dermatol; 2015 Sep; 73(3):471-6. PubMed ID: 26282797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
